Carbocyclic thymidine analogues for use as potential therapeutic agents.
The discovery of azidothymidine's (AZT) activity against human immunodeficiency virus (HIV) provided strong rationale for the design of additional thymidine analogues. One drawback of many nucleoside analogues is the toxicity that often arises due to phosphorylation by cellular kinases. In order to overcome this problem, a number of truncated nucleosides lacking the 4'-hydroxymethyl group have been synthesized. In that regard, the synthesis and preliminary biological results for two truncated carbocyclic thymidine analogues are presented herein.
Seley-Radtke
Katherine L
KL
Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, Maryland, USA. kseley@umbc.edu
Sunkara
Naresh K
NK
D000998:Antiviral Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D002460:Cell Line; D006801:Humans; D013936:Thymidine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology*; D014780:Viruses / Q000187:drug effects
D000998:Antiviral Agents; D013936:Thymidine